Methylenedioxybutylamphetamine
Methylenedioxybutylamphetamine (MDBA) is a psychoactive drug and a member of the phenethylamine and amphetamine chemical classes. It is known for its entactogenic effects, similar to those of MDMA, but with a longer duration of action.
History[edit]
MDBA was first synthesized in the 1960s by Alexander Shulgin, a renowned chemist and psychopharmacologist. It was later included in Shulgin's book PiHKAL (Phenethylamines I Have Known And Loved), where it was described as a potent entactogen with effects lasting up to 12 hours.
Pharmacology[edit]
MDBA acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). It increases the levels of these neurotransmitters in the brain by promoting their release from neurons and inhibiting their reuptake. This results in increased neuronal activity and stimulation of the central nervous system.
Effects[edit]
The effects of MDBA can vary greatly depending on the dose, the individual's physiology, and the environment in which it is taken. Common effects include feelings of euphoria, increased sociability, heightened sensory perception, and increased energy. However, it can also cause negative effects such as anxiety, paranoia, and potentially dangerous increases in heart rate and blood pressure.
Legal Status[edit]
In many countries, including the United States, MDBA is classified as a Schedule I drug under the Controlled Substances Act. This means it is illegal to manufacture, distribute, or possess without a license or prescription.
Health Risks[edit]
Like other amphetamines, MDBA can be harmful or potentially fatal if misused. Risks include cardiovascular disease, neurotoxicity, and psychological addiction. It is strongly advised that individuals with a history of mental health issues, particularly mood disorders such as depression or bipolar disorder, avoid use due to the potential for exacerbating these conditions.
See Also[edit]
This article is a Psychoactive drug-related stub. You can help WikiMD by expanding it!

This article is a Amphetamine-related stub. You can help WikiMD by expanding it!
-
Methylenedioxybutylamphetamine structure
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian